Algernon Pharmaceuticals (TSE:AGN) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Algernon Pharmaceuticals, a Canadian clinical stage drug development company, has announced an increase in its non-brokered private placement from $250,000 to $408,000, with each unit consisting of a common share and a purchase warrant. The offering is set to close on August 1, 2024, and the proceeds will be used for working capital purposes. The warrants have an accelerated expiry clause if the company’s share price exceeds certain thresholds.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.